Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2024. Start Trial.
Date Value
September 30, 2026 11.80B
June 30, 2026 11.57B
March 31, 2026 11.27B
December 31, 2025 10.74B
Date Value
September 30, 2025 17.14B
June 30, 2025 16.95B
March 31, 2025
December 31, 2024 16.52B

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 51.03B
AngioDynamics, Inc. 163.96M
Alphatec Holdings, Inc. 21.30M
AtriCure, Inc. 533.22M
Baxter International, Inc. 6.502B

Shareholders Equity (Quarterly) Related Metrics